Trevi Therapeutics Stock Performance
as on October 12, 2026 at 2:16 pm IST
Day's Low
Day's High
$12.52$13.30
5.08%
Downside
0.83%
Upside
52 Week's Low
52 Week's High
$9.28$20.2229.64%
Downside
53.30%
Upside
Trevi Therapeutics share price movements today
- Previous Close
- $12.82
- Open
- $12.71
- Volume
- 1.7M
- Market Cap
- $1.9B
- Day's Low - High
- $12.52 - $13.30
- 52 Week Low - High
- $9.28 - $20.22
Trevi Therapeutics Historical Returns
- 1 Month Return
- -17.04 %
- 3 Month Return
- -26.07 %
- 1 Year Return
- + 32.03 %
- 3 Year Return
- + 559.5 %
- 5 Year Return
- + 822.38 %
Trevi Therapeutics Stock Fundamentals & Key Indicators
Check Trevi Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.9B
EPS (TTM)
-0.3378
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-39.05
Industry PE ratio
-6.44
PEG Ratio
-2.05
EBITDA
-51.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-23.59%
Trevi Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Trevi Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $1.9B | 822.38% | -39.05 | 0.00% | 0.00% | |
| Neutral | $89.8B | -27.68% | -28.20 | -12.57% | 0.00% | |
| StrongBuy | $129.3B | 183.05% | 29.45 | 86.04% | 0.00% | |
| Buy | $76.9B | 37.12% | 17.83 | 84.86% | 0.50% |
Stock Returns calculator for Trevi Therapeutics Stock including INR - Dollar returns
The Trevi Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Trevi Therapeutics investment value today
Current value as on today
₹1,42,597
Returns
₹42,597
(+42.6%)
Returns from Trevi Therapeutics Stock
₹32,032 (+32.03%)
Dollar Impact
₹10,565 (+10.57%)
Analyst Recommendation on Trevi Therapeutics Stock
Based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Trevi Therapeutics. Average target price of $28.18
Trevi Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Trevi Therapeutics.
What analysts predicted
53.19%UPSIDE
Target Price
$28.18
Current Price
$13.19
Analyzed by
7 Analysts
High
$40
Target
$28.18
Low
$23
Trevi Therapeutics target price $28.18, a slight upside of 53.19% compared to current price of $13.19. According to 7 analysts rating.
Indian Investors' Interest in Trevi Therapeutics Stock
Search interest for Trevi Therapeutics Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Trevi Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Trevi Therapeutics Annual Profit & Loss
All numbers in Millions USD
Trevi Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Trevi Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Trevi Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 years, TRVI stock has moved up by 559.5%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TRVI has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 706.6%
About Trevi Therapeutics
| Organisation | Trevi Therapeutics |
| Headquarters | 195 Church Street, New Haven, CT, 06510, US |
| Industry | Biotechnology |
| CEO | Jennifer L. Good |
Key Management of Trevi Therapeutics
Name | Title |
|---|---|
Dr. Thomas R. Sciascia M.D. | Co-Founder & Chief Scientific Officer |
Mr. David C. Hastings CPA | Chief Financial Officer & Principal Financial Officer |
Mr. Christopher Galletta | Controller & Chief Accounting Officer |
Katie McManus | Communications Manager |
Ms. Jennifer L. Good | Co-Founder, CEO, President, & Director |
Dr. James V. Cassella Ph.D. | Chief Development Officer |
Dr. Farrell Simon Pharm.D. | Chief Commercial Officer |
FAQs
What is Trevi Therapeutics share price today?
Trevi Therapeutics share price today is $13.19 as on at the close of the market. Trevi Therapeutics share today touched a day high of $13.30 and a low of $12.52.
What is the 52 week high and 52 week low for Trevi Therapeutics share?
Trevi Therapeutics share touched a 52 week high of $20.22 on and a 52 week low of $9.28 on . Trevi Therapeutics stock price today i.e. is closed at $13.19,which is 34.77% down from its 52 week high and 42.13% up from its 52 week low.
What is Trevi Therapeutics's market capitalisation today?
Trevi Therapeutics market capitalisation is $0.00T as on .
How to invest in Trevi Therapeutics Stock (TRVI) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Trevi Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Trevi Therapeutics Stock (TRVI) from India?
Indian investors can start investing in Trevi Therapeutics (TRVI) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Trevi Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Trevi Therapeutics share’s latest price of $13.19 as on October 12, 2026 at 8:46 am IST, you will get 0.7582 shares of Trevi Therapeutics. Learn more about
fractional shares .
What are the returns that Trevi Therapeutics has given to Indian investors in the last 5 years?
Trevi Therapeutics stock has given 822.38% share price returns and 28.2% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?